Trials / Completed
CompletedNCT01704521
Viral Kinetics in HCV Clearance in Subjects With Hemophilia
Viral Kinetic Models of HCV Clearance in Hemophiliacs With Telaprevir
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Kenneth Sherman · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will examine viral dynamic responses in subjects with chronic hepatitis C and hemophilia when treated with pegylated interferon + ribavirin and telaprevir.
Detailed description
Previous clinical trials for treatment of chronic hepatitis C have excluded subjects with hemophilia from participating.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PegInterferon | |
| DRUG | Ribavirin | |
| DRUG | Telaprevir |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2014-10-01
- Completion
- 2014-10-01
- First posted
- 2012-10-11
- Last updated
- 2015-04-06
- Results posted
- 2015-04-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01704521. Inclusion in this directory is not an endorsement.